Camlin Fine Sciences Promoter Pledges Additional 37.50 Lakh Shares to Two Lenders
Camlin Fine Sciences promoter Ashish Subhash Dandekar has pledged an additional 37.50 lakh equity shares to two NBFCs - Aditya Birla Capital Limited and SKS Fincap Private Limited. The pledges, created on April 7-8, 2026, increase total encumbered shareholding to 1.91 crore shares (9.92% of share capital), representing 96.32% of the promoter's total holding.

*this image is generated using AI for illustrative purposes only.
Camlin Fine Sciences promoter Ashish Subhash Dandekar has pledged additional equity shares to two financial institutions as margin for financial assistance, according to regulatory disclosures filed on April 13, 2026. The pledges were created on April 7 and April 8, 2026, in favor of Aditya Birla Capital Limited and SKS Fincap Private Limited respectively.
Share Pledge Details
The latest encumbrances involve a total of 37.50 lakh equity shares across two separate transactions, representing 1.95% of the company's total share capital. These pledges were created to address security cover requirements for financial assistance obtained by the target company.
| Parameter: | Transaction 1 | Transaction 2 |
|---|---|---|
| Shares Pledged: | 12.50 lakh | 25.00 lakh |
| Percentage of Share Capital: | 0.65% | 1.30% |
| Date of Pledge: | April 7, 2026 | April 8, 2026 |
| Beneficiary: | Aditya Birla Capital Limited | SKS Fincap Private Limited |
| Type of Encumbrance: | Pledge | Pledge |
| Share Value on Event Date: | ₹12.98 crore | ₹27.35 crore |
Updated Promoter Shareholding Position
Following these transactions, Dandekar's total encumbered shareholding has increased substantially. The promoter maintains a 10.30% stake in the company while using a significant portion as collateral for financial arrangements.
| Shareholding Details: | Current Position |
|---|---|
| Total Promoter Holding: | 1.98 crore shares (10.30%) |
| Previously Encumbered: | 1.53 crore shares (7.96%) |
| Additional Pledges: | 37.50 lakh shares (1.95%) |
| Total Encumbered Shares: | 1.91 crore shares (9.92%) |
| Encumbered as % of Promoter Holding: | 96.32% |
Financial Institution Details
Both beneficiary entities are established financial institutions. Aditya Birla Capital Limited operates as a non-banking financial company (NBFC), while SKS Fincap Private Limited also functions as an NBFC. The second transaction with SKS Fincap involves a borrowing amount of ₹10.00 crore against pledged shares valued at ₹27.35 crore, providing a security cover ratio of 2.73.
| Institution Details: | Aditya Birla Capital | SKS Fincap Private |
|---|---|---|
| Entity Type: | NBFC | NBFC |
| Amount Involved: | Not specified | ₹10.00 crore |
| Security Cover Ratio: | Not applicable | 2.73 |
| Purpose: | Margin pledge for security cover | Facilitate company borrowing |
Regulatory Compliance Framework
The disclosures were made in compliance with Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The official regulatory filing confirms that while the encumbered shares represent more than 50% of the promoter's shareholding, they constitute less than 20% of the company's total share capital.
| Compliance Parameter: | Status |
|---|---|
| Encumbered Share ≥ 50% of Promoter Holding: | YES |
| Encumbered Share ≥ 20% of Total Share Capital: | NO |
| Stock Exchanges Notified: | BSE Limited, NSE |
| Reporting Date: | April 13, 2026 |
Purpose and Utilization
The encumbrances serve specific purposes related to the company's financial requirements. The first pledge with Aditya Birla Capital was created as additional margin for covering shortfall in security cover with respect to financial assistance obtained for acquiring shares of the target company. The second pledge with SKS Fincap was specifically created to facilitate borrowing by the target company, demonstrating the promoter's commitment to supporting the company's capital requirements and operational needs.
Historical Stock Returns for Camlin Fine Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.32% | +18.62% | +20.14% | -36.95% | -22.16% | -17.27% |
What impact could the 96.32% encumbrance of promoter holdings have on Camlin Fine Sciences' stock liquidity and investor confidence?
How might this high level of share pledging affect the company's ability to raise equity capital or pursue strategic acquisitions in the future?
What are the potential consequences if Camlin Fine Sciences faces financial stress and the pledged shares need to be invoked by the lenders?


































